Is Halozyme Therapeutics, Inc. technically bullish or bearish?

As of 31 October 2025, the technical trend for Halozyme Therapeutics, Inc. has changed from bullish to mildly bullish. The weekly MACD is mildly bearish, while the monthly MACD remains bullish. The daily moving averages indicate a mildly bullish stance. The KST and Dow Theory are both bullish on a weekly and monthly basis, suggesting underlying strength. However, the weekly OBV is mildly bearish, which could indicate some selling pressure.
In terms of performance, the stock has underperformed the S&P 500 over the past week and month, with returns of -1.45% and -13.01% compared to the S&P 500's gains of 0.71% and 1.92%, respectively. However, year-to-date and one-year returns are strong at 36.35% and 28.91%, respectively, outperforming the S&P 500's 16.30% and 19.89%. Overall, the current stance is mildly bullish, with mixed signals across different indicators.